$NURO
NeuroMetrix, Inc. Stock $nuro

$nuro Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-Q Financial Statement

#000162828017010010 Filed on October 20, 2017

Income Statement

Concept	2017 Q4	2017 Q3	2016 Q3
Revenue	$4.930M	$3.547M	$3.389M
YoY Change	32.53%	4.64%	64.98%
Cost Of Revenue	$2.860M	$2.041M	$2.032M
YoY Change	40.89%	0.45%	81.54%
Gross Profit	$2.070M	$1.506M	$1.358M
YoY Change	22.49%	10.91%	45.16%
Gross Profit Margin	41.99%	42.45%	40.05%
Selling, General & Admin	$4.080M	$4.178M	$4.125M
YoY Change	11.78%	1.28%	23.07%
% of Gross Profit	197.1%	277.48%	303.85%
Research & Development	$880.0K	$840.6K	$1.203M
YoY Change	-3.3%	-30.11%	27.83%
% of Gross Profit	42.51%	55.83%	88.59%
Depreciation & Amortization	$60.00K	$70.00K	$70.00K
YoY Change	0.0%	0.0%	16.67%
% of Gross Profit	2.9%	4.65%	5.16%
Operating Expenses	$4.950M	$5.019M	$5.328M
YoY Change	8.79%	-5.8%	24.12%
Operating Profit	-$2.880M	-$3.513M	-$3.970M
YoY Change	0.7%	-11.52%	18.25%
Interest Expense	$0.00	$0.00	$60.00K
YoY Change	-100.0%	-100.0%	-60.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$2.880M	-$3.510M	-$3.910M
YoY Change	2.49%	-10.23%	22.19%
Income Tax
% Of Pretax Income
Net Earnings	-$2.880M	-$3.509M	-$3.908M
YoY Change	2.49%	-10.21%	21.99%
Net Earnings / Revenue	-58.42%	-98.94%	-115.3%
Basic Earnings Per Share		-$3.11
Diluted Earnings Per Share	-$11.52M	-$3.11	-$65.17M
COMMON SHARES
Basic Shares Outstanding	2.346M shares	2.036M shares
Diluted Shares Outstanding		2.036M shares

Balance Sheet

Concept	2017 Q4	2017 Q3	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.040M	$3.970M	$7.570M
YoY Change	2.28%	-47.56%	-17.0%
Cash & Equivalents	$4.044M	$3.969M	$7.568M
Short-Term Investments
Other Short-Term Assets	$2.640M	$2.040M	$1.290M
YoY Change	60.0%	58.14%	46.59%
Inventory	$2.143M	$1.786M	$1.160M
Prepaid Expenses
Receivables	$1.049M	$423.4K	$570.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$9.103M	$8.221M	$10.59M
YoY Change	19.99%	-22.37%	-11.53%
LONG-TERM ASSETS
Property, Plant & Equipment	$440.8K	$417.3K	$580.0K
YoY Change	-17.24%	-28.05%	-22.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$60.00K	$130.0K	$170.0K
YoY Change	-62.5%	-23.53%	-19.05%
Total Long-Term Assets	$495.9K	$552.0K	$760.0K
YoY Change	-28.86%	-27.37%	-20.83%
TOTAL ASSETS
Total Short-Term Assets	$9.103M	$8.221M	$10.59M
Total Long-Term Assets	$495.9K	$552.0K	$760.0K
Total Assets	$9.599M	$8.773M	$11.35M
YoY Change	15.88%	-22.71%	-12.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$733.3K	$725.2K	$710.0K
YoY Change	-0.1%	2.14%	-25.26%
Accrued Expenses	$2.362M	$1.911M	$1.810M
YoY Change	43.27%	5.58%	-4.74%
Deferred Revenue	$820.0K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.582M	$4.255M	$3.590M
YoY Change	38.07%	18.52%	1.48%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$0.00	$50.00K
YoY Change		-100.0%	-94.44%
Total Long-Term Liabilities	$0.00	$0.00	$50.00K
YoY Change		-100.0%	-94.44%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.582M	$4.255M	$3.590M
Total Long-Term Liabilities	$0.00	$0.00	$50.00K
Total Liabilities	$4.582M	$4.255M	$3.640M
YoY Change	37.88%	16.9%	-17.99%
SHAREHOLDERS EQUITY
Retained Earnings	-$191.3M	-$188.5M
YoY Change	7.2%
Common Stock	$271.00	$215.00
YoY Change	222.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.017M	$4.518M	$7.710M
YoY Change
Total Liabilities & Shareholders Equity	$9.599M	$8.773M	$11.35M
YoY Change	15.88%	-22.71%	-12.21%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2016 Q3
OPERATING ACTIVITIES
Net Income	-$2.880M	-$3.509M	-$3.908M
YoY Change	2.49%	-10.21%	21.99%
Depreciation, Depletion And Amortization	$60.00K	$70.00K	$70.00K
YoY Change	0.0%	0.0%	16.67%
Cash From Operating Activities	-$3.170M	-$2.870M	-$3.660M
YoY Change	-12.43%	-21.58%	6.71%
INVESTING ACTIVITIES
Capital Expenditures	-$90.00K	-$30.00K	-$30.00K
YoY Change	800.0%	0.0%	-66.67%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$90.00K	-$30.00K	-$30.00K
YoY Change	800.0%	0.0%	-66.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.340M	3.260M	-70.00K
YoY Change	16600.0%	-4757.14%
NET CHANGE
Cash From Operating Activities	-3.170M	-2.870M	-3.660M
Cash From Investing Activities	-90.00K	-30.00K	-30.00K
Cash From Financing Activities	3.340M	3.260M	-70.00K
Net Change In Cash	80.00K	360.0K	-3.760M
YoY Change	-102.22%	-109.57%	6.82%
FREE CASH FLOW
Cash From Operating Activities	-$3.170M	-$2.870M	-$3.660M
Capital Expenditures	-$90.00K	-$30.00K	-$30.00K
Free Cash Flow	-$3.080M	-$2.840M	-$3.630M
YoY Change	-14.68%	-21.76%	8.68%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001289850
CY2017Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2345519	shares
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Entity Registrant Name EntityRegistrantName	NeuroMetrix, Inc.
	dei	Trading Symbol TradingSymbol	NURO
CY2016Q4	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	488200	USD
CY2017Q3	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	454730	USD
CY2016Q4	nuro	Common Stock Warrants CommonStockWarrants	4641	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	6650316	USD
CY2017Q3	nuro	Common Stock Warrants CommonStockWarrants	0	USD
CY2016Q4	nuro	Common Stock Warrants Fair Value Disclosure CommonStockWarrantsFairValueDisclosure	4641	USD
	nuro	Exchange Of Warrant Liability For Preferred Stock ExchangeOfWarrantLiabilityForPreferredStock	0	USD
	nuro	Exchange Of Warrant Liability For Preferred Stock ExchangeOfWarrantLiabilityForPreferredStock	-40772	USD
	nuro	Fair Value Adjustmentof Warrants Repricing FairValueAdjustmentofWarrantsRepricing	0	USD
	nuro	Fair Value Adjustmentof Warrants Repricing FairValueAdjustmentofWarrantsRepricing	244611	USD
CY2017Q3	nuro	Restricted Cash Collateral Letters Of Credit RestrictedCashCollateralLettersOfCredit	226731	USD
	nuro	Stock Issuance Settle Incentive Compensation Obligation StockIssuanceSettleIncentiveCompensationObligation	318761	USD
	nuro	Stock Issuance Settle Incentive Compensation Obligation StockIssuanceSettleIncentiveCompensationObligation	0	USD
CY2016Q4	nuro	Technology Fees TechnologyFees	450000	USD
CY2017Q3	nuro	Technology Fees TechnologyFees	450000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	734048	USD
CY2017Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	725224	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	738729	USD
CY2017Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	423444	USD
CY2016Q4	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	28100	USD
CY2017Q3	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	335600	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1648731	USD
CY2017Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1911062	USD
CY2016Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	390800	USD
CY2017Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	343000	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	183439463	USD
CY2017Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	192975377	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	25000	USD
CY2017Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	25000	USD
CY2016Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4971423	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3643286	shares
CY2017Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7728775	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7896343	shares
CY2016Q4	us-gaap	Assets Assets	8283891	USD
CY2017Q3	us-gaap	Assets Assets	8772656	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	7586923	USD
CY2017Q3	us-gaap	Assets Current AssetsCurrent	8220671	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12462872	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7568186	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3949135	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3969218	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4000000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4894686	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	20083	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	9569800	USD
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	836862	shares
CY2017Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2145519	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	836862	shares
CY2017Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2145519	shares
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10147721	shares
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1268440	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	84	USD
CY2017Q3	us-gaap	Common Stock Value CommonStockValue	215	USD
CY2016Q3	us-gaap	Cost Of Revenue CostOfRevenue	2031823	USD
	us-gaap	Cost Of Revenue CostOfRevenue	5086706	USD
CY2017Q3	us-gaap	Cost Of Revenue CostOfRevenue	2040997	USD
	us-gaap	Cost Of Revenue CostOfRevenue	7378001	USD
CY2016Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	910595	USD
CY2017Q3	us-gaap	Deferred Costs Current DeferredCostsCurrent	1466230	USD
CY2016Q4	us-gaap	Deferred Revenue And Credits Current DeferredRevenueAndCreditsCurrent	1247545	USD
CY2017Q3	us-gaap	Deferred Revenue And Credits Current DeferredRevenueAndCreditsCurrent	2272736	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	628236	USD
CY2017Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	925794	USD
	us-gaap	Depreciation Depreciation	189224	USD
	us-gaap	Depreciation Depreciation	198892	USD
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-6.11
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-56.09
CY2017Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.11
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-11.62
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	307471	USD
CY2017Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	692937	USD
CY2017Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	418881	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y7M6D
CY2016Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-56248	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-227873	USD
CY2017Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-327	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-208480	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	40772	USD
CY2016Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1165815	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3882461	USD
CY2017Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1258466	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3925595	USD
CY2016Q3	us-gaap	Gross Profit GrossProfit	1357604	USD
	us-gaap	Gross Profit GrossProfit	3225390	USD
CY2017Q3	us-gaap	Gross Profit GrossProfit	1505683	USD
	us-gaap	Gross Profit GrossProfit	4784860	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-287427	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-22074	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-236447	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-315285	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	634181	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	647797	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	1252238	USD
CY2017Q3	us-gaap	Inventory Net InventoryNet	1786074	USD
CY2016Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	466906	USD
CY2017Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	914150	USD
CY2016Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	154971	USD
CY2017Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	91335	USD
CY2016Q4	us-gaap	Liabilities Liabilities	3323127	USD
CY2017Q3	us-gaap	Liabilities Liabilities	4255017	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8283891	USD
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8772656	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3318486	USD
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4255017	USD
	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2018-01-15
CY2017Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	2500000	USD
CY2017Q3	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	2300000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	402178	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	297558	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	73072	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	533836	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	408532	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	365547	USD
CY2016Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	5772	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	17030	USD
CY2017Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	3554	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	11018	USD
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	630361	USD
CY2017Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	780589	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-87884	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-70226	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-11457118	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-9479491	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-3908153	USD
	us-gaap	Net Income Loss NetIncomeLoss	-12098928	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-3508983	USD
	us-gaap	Net Income Loss NetIncomeLoss	-9979179	USD
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3908153	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-31945305	USD
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-6342081	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-16853959	USD
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	5327777	USD
	us-gaap	Operating Expenses OperatingExpenses	15569221	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	5018547	USD
	us-gaap	Operating Expenses OperatingExpenses	14983537	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3970173	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12343831	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3512864	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10198677	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	245752	USD
	us-gaap	Proceeds From Repurchase Of Equity ProceedsFromRepurchaseOfEquity	9569800	USD
CY2016Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	45879	USD
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-188500000	USD
CY2017Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	112008	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	532706	USD
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	417290	USD
CY2016	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	488200	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	454730	USD
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1202651	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	569555	shares
CY2017Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	2036117	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1450237	shares
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3487291	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	840577	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2621445	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-178478801	USD
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-188457980	USD
CY2017Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	215724	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2016Q4	us-gaap	Other Deferred Credits Current OtherDeferredCreditsCurrent	619309	USD
CY2017Q3	us-gaap	Other Deferred Credits Current OtherDeferredCreditsCurrent	1346942	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	87884	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	70226	USD
CY2016Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	USD
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	19846377	USD
CY2017Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	2833098	USD
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	6874780	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1646821	USD
CY2017Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2041935	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	164262	USD
CY2017Q3	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	134695	USD
	us-gaap	Proceeds From Repurchase Of Equity ProceedsFromRepurchaseOfEquity	6650316	USD
CY2016Q3	us-gaap	Revenues Revenues	3389427	USD
	us-gaap	Revenues Revenues	8312096	USD
CY2017Q3	us-gaap	Revenues Revenues	3546680	USD
	us-gaap	Revenues Revenues	12162861	USD
CY2016Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2959311	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	8199469	USD
CY2017Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2919504	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	8436497	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	176684	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	170093	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	4960764	USD
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	4517639	USD
CY2017Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.125
CY2016Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	639512	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001628280-17-010010-index-headers.html	Edgar Link	pending
0001628280-17-010010-index.html	Edgar Link	pending
0001628280-17-010010.txt	Edgar Link	pending
0001628280-17-010010-xbrl.zip	Edgar Link	pending
a10q9302017document.htm	Edgar Link	pending
a10q9302017exhibit311.htm	Edgar Link	pending
a10q9302017exhibit312.htm	Edgar Link	pending
a10q9302017exhibit32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nuro-20170930.xml	Edgar Link	completed
nuro-20170930.xsd	Edgar Link	pending
nuro-20170930_cal.xml	Edgar Link	unprocessable
nuro-20170930_def.xml	Edgar Link	unprocessable
nuro-20170930_lab.xml	Edgar Link	unprocessable
nuro-20170930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NURO
NeuroMetrix, Inc. Stock $nuro

2017 Q4 Form 10-Q Financial Statement

#000162828017010010 Filed on October 20, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO NeuroMetrix, Inc. Stock $nuro

2017 Q4 Form 10-Q Financial Statement

#000162828017010010 Filed on October 20, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO
NeuroMetrix, Inc. Stock $nuro